RHUMBLINE ADVISERS - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$409,983
-32.1%
131,408
-0.1%
0.00%
-100.0%
Q2 2023$603,580
+90121.2%
131,499
-2.7%
0.00%0.0%
Q1 2023$669
-4.3%
135,143
+5.5%
0.00%0.0%
Q4 2022$699
-99.9%
128,071
+1.2%
0.00%0.0%
Q3 2022$823,000
+45.9%
126,587
+6.2%
0.00%0.0%
Q2 2022$564,000
-23.1%
119,184
+13.6%
0.00%0.0%
Q1 2022$733,000
-23.2%
104,878
+11.9%
0.00%0.0%
Q4 2021$955,000
+629.0%
93,694
+772.6%
0.00%
Q3 2021$131,00010,7370.00%
Other shareholders
MAXCYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,885,000$5,881,2005.55%
Vitruvian Partners LLP 5,043,356$15,735,2714.46%
Stonepine Capital Management, LLC 3,761,640$11,736,3173.90%
Mudita Advisors LLP 1,390,858$4,339,4773.17%
RIVER GLOBAL INVESTORS LLP 1,473,254$4,588,3591.07%
Casdin Capital, LLC 1,890,000$5,896,8000.65%
Portolan Capital Management 2,143,666$6,688,2380.62%
Grandeur Peak Global Advisors, LLC 1,434,819$4,476,6350.34%
First Light Asset Management, LLC 1,073,110$3,348,1030.32%
Granahan Investment Management 1,975,847$6,164,6430.22%
View complete list of MAXCYTE INC shareholders